Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CFSAN Offices Of Special Nutritionals, Food Labeling To Merge

This article was originally published in The Tan Sheet

Executive Summary

FDA's Center for Food Safety & Applied Nutrition is going to combine its Office of Special Nutritionals and Office of Food Labeling into one unit.

You may also be interested in...



CFSAN's Yetley To Lead Nutrition Scientist; Lewis Overseeing New Office

Former CFSAN Office of Special Nutritionals Director Elizabeth Yetley, PhD, has been promoted to FDA Lead Scientist for Nutrition within the center.

CFSAN's Yetley To Lead Nutrition Scientist; Lewis Overseeing New Office

Former CFSAN Office of Special Nutritionals Director Elizabeth Yetley, PhD, has been promoted to FDA Lead Scientist for Nutrition within the center.

CFSAN's Yetley To Lead Nutrition Scientist; Lewis Overseeing New Office

Former CFSAN Office of Special Nutritionals Director Elizabeth Yetley, PhD, has been promoted to FDA Lead Scientist for Nutrition within the center.

Topics

UsernamePublicRestriction

Register

LL1134420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel